51 results on '"Namdar, Afshin"'
Search Results
2. Corrigendum to “Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240]
3. The prognostic and therapeutic potential of HO-1 in leukemia and MDS
4. Retraction Note: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
5. Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions
6. Interaction of M2 macrophages with hepatocellular carcinoma co-culture system in the presence of doxorubicin-loaded nanoparticles
7. Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma
8. Interaction of M2 Macrophages with Hepatocellular Carcinoma Co-Culture System in the Presence of Doxorubicin-Loaded Nanoparticles
9. Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10
10. Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth
11. EP4 receptor as a novel promising therapeutic target in colon cancer
12. Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
13. Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib
14. Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
15. RETRACTED ARTICLE: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
16. Antitumor immunity in dMMR colorectal cancers requires interferon-induced CCL5 and CXCL10
17. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression
18. CDK1 in Breast Cancer: Implications for Theranostic Potential
19. Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses
20. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy
21. Coinhibition of S1PR1 and GP130 by siRNA‐loaded alginate‐conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells
22. IFN-lambda 3 directly induces antiviral responses in human B and T cells leading to inhibition of HIV-1 infection of CD4+ T cells
23. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
24. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target
25. CD71 + Erythroid Cells Exacerbate HIV-1 Susceptibility, Mediate trans -Infection, and Harbor Infective Viral Particles
26. Long Non-Coding RNAs As Epigenetic Regulators in Cancer
27. Conjugated CAR T cell one step beyond conventional CAR T cell for a promising cancer immunotherapy
28. Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine
29. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
30. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer
31. Natural Killer Cells Exhibit an Activated Phenotype in Peripheral Blood Mononuclear Cells of Renal Allograft Rejection Recipients: A Preliminary Study
32. Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway
33. CD71+erythroid cells exacerbate HIV-1 infection by reactive oxygen species and trans-infect HIV to CD4+T cells
34. Importance of probiotics in the prevention and treatment of colorectal cancer
35. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer
36. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β
37. Predictive and therapeutic biomarkers in chimeric antigen receptor T‐cell therapy: A clinical perspective
38. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis
39. Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model
40. Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling
41. Erythroid Suppressor Cells Compromise Neonatal Immune Response against Bordetella pertussis
42. CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis
43. Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
44. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
45. Improved Anti-Treg Vaccination Targeting Foxp3 Efficiently Decreases Regulatory T Cells in Mice
46. Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer
47. Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity
48. Olive Leaf Extract Reduces Myeloid-Derived Suppressor Cells, and Modulates the Function of Residual Cells in Experimental Model of Melanoma
49. Low Noncytotoxic Concentrations of 5-Fluorouracil Have No Adverse Effects on Maturation and Function of Bone Marrow-Derived Dendritic Cells in vitro: A Potentially Safe Adjuvant for Dendritic Cell-Based Cancer Therapy
50. Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.